Hemophagocytic Lympho Histiocytosis (HLH) | Abstract
international journal of bioassays.
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Hemophagocytic Lympho Histiocytosis (HLH)

Author(s): Nijwm Mahilary, Rajib Ray, Rameswar Prasad Mishra, Raj Kumar Paul*


Hemophagocytic lymphohistiocytosis (HLH) is a potentially fatal hyper-inflammatory condition caused by a highly stimulated, but ineffective immune response, characterized by a dys-regulated activation and proliferation of macrophages leading to uncontrolled phagocytosis of platelets, erythrocytes, lymphocytes and their hematopoietic precursors throughout the reticulo-endothelial system. HLH is a distinct clinical entity characterized by fever, pancytopenia, splenomegaly and hemophagocytosis in bone marrow, liver, or lymph nodes. HLH also occurs as a complication of rheumatic diseases and of malignancies. Awareness of the clinical symptoms and of diagnostic criteria for HLH (Histiocyte society; HLH study 2004) is crucial to starting life-saving therapy in time. We have reported a case of 7-year-old male child presenting with respiratory distress, distension of abdomen and deep jaundice. This case report may be an eye opener to the pediatricians and other physicians to recognize this rare entity of infection triggering fatal HLH and thus proper treatment may be instituted in those affected with this disease at the earliest.

Share this article

International Journal of Bioassays is a member of the Publishers International Linking Association, Inc. (PILA), CROSSREF and CROSSMARK (USA). Digital Object Identifier (DOI) will be assigned to all its published content.

International Journal of Bioassays [ISSN: International Journal of Bioassays] is licensed under
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© Copyright 2012-2023. All rights reserved.